Cochrane · systematic review · CD010051

Topical cyclosporine A therapy for dry eye syndrome

de Paiva, CS, Pflugfelder, SC, Ng, SM, et al. · Cochrane Database of Systematic Reviews · 2019 · Cochrane Library

Eyes and VisionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 7 · 100%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Topical cyclosporine A 0.05% + artificial tears versus vehicle + artificial tears or artificial tears alone for dry eye syndrome

Population: People with dry eye syndrome
7 questions
OutcomeEffectEvidenceStatus / GRADE
Subjective symptoms of dry eye at 6 months
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
no estimate extracted1 study · 56 participantsLow
Downgraded: risk of bias, imprecision
Ocular surface dye staining at 6 months
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
no estimate extracted2 studies · 291 participantsLow
Downgraded: risk of bias, inconsistency
Aqueous tear production measured by Schirmer test scores (mm/5 minutes) at 6 months
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
no estimate extracted4 studies · 406 participantsLow
Downgraded: risk of bias, inconsistency
Tear film stability measured by tear break‐up time (seconds) at 6 months
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
no estimate extracted5 studies · 676 participantsLow
Downgraded: risk of bias, inconsistency
Frequency of artificial tear usage at 6 months
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
no estimate extracted3 studies · 910 participantsLow
Downgraded: risk of bias, inconsistency
Conjunctival goblet cell density (cells per unit) at 6 months
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
no estimate extracted2 studies · 100 participantsLow
Downgraded: risk of bias, imprecision
Treatment related adverse events,
Topical cyclosporine A 0.05% + artificial tears vs vehicle + artificial tears or artificial tears alone
no estimate extracted3 studies · 743 participantsLow
Downgraded: risk of bias, imprecision